Real-world safety assessment of burosumab: a pharmacovigilance study utilizing the FDA adverse event reporting system.

HOME
>
論文・技術情報
>
Real-world safety assessment of burosumab: a pharmacovigilance study utilizing the FDA adverse event reporting system.

アブストラクト
ジャーナル名	Orphanet journal of rare diseases
Pubmed追加日	2026/2/28
投稿者	Chen, Tingting; Liang, Min
組織名	The Department of Geriatric Endocrinology and Metabolism, The First Affiliated;Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi,;530021, China.;530021, China. liangm@gxmu.edu.cn.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/41761237/